1. Home
  2. ALGT vs IMNM Comparison

ALGT vs IMNM Comparison

Compare ALGT & IMNM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Allegiant Travel Company

ALGT

Allegiant Travel Company

HOLD

Current Price

$76.01

Market Cap

2.9B

ML Signal

HOLD

Logo Immunome Inc.

IMNM

Immunome Inc.

HOLD

Current Price

$27.97

Market Cap

2.5B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
ALGT
IMNM
Founded
1997
2006
Country
United States
United States
Employees
N/A
N/A
Industry
Air Freight/Delivery Services
Medicinal Chemicals and Botanical Products
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
2.9B
2.5B
IPO Year
2006
2020

Fundamental Metrics

Financial Performance
Metric
ALGT
IMNM
Price
$76.01
$27.97
Analyst Decision
Hold
Strong Buy
Analyst Count
10
10
Target Price
$97.30
$32.80
AVG Volume (30 Days)
473.6K
1.1M
Earning Date
04-30-2026
05-08-2026
Dividend Yield
N/A
N/A
EPS Growth
81.62
51.40
EPS
1.80
N/A
Revenue
$2,606,579,000.00
$6,941,000.00
Revenue This Year
$9.42
N/A
Revenue Next Year
$6.52
$1,127.34
P/E Ratio
$43.37
N/A
Revenue Growth
3.74
N/A
52 Week Low
$56.64
$8.67
52 Week High
$123.63
$30.06

Technical Indicators

Market Signals
Indicator
ALGT
IMNM
Relative Strength Index (RSI) 27.21 63.61
Support Level $72.44 $18.72
Resistance Level $94.59 N/A
Average True Range (ATR) 4.57 1.56
MACD -1.91 0.27
Stochastic Oscillator 5.24 75.57

Price Performance

Historical Comparison
ALGT
IMNM

About ALGT Allegiant Travel Company

Allegiant Travel Co is a leisure travel company focused on providing travel and leisure services and products to residents of underserved cities in the United States. It operates a low-cost, low utilization passenger airline marketed to leisure travelers in underserved cities, allowing it to sell air transportation both on a stand-alone basis and bundled with the sale of air-related and third-party services and products. In addition, it provides air transportation under fixed-fee flight arrangements. In connection with its leisure travel focus, the company has opened Sunseeker Resort Charlotte Harbor, equipped with several guestrooms and food and beverage outlets. The company's operating segments are the Airline, which generates the maximum revenue, and Sunseeker Resort.

About IMNM Immunome Inc.

Immunome Inc is a biotechnology company focused on developing first-in-class targeted oncology therapies. The company specializes in the discovery, design, development, manufacturing, and commercialization of antibody-drug conjugates and other oncology therapeutics. Its pipeline includes varegacestat, an investigational oral gamma secretase inhibitor that reported positive topline results in the Phase 3 RINGSIDE trial for progressing desmoid tumors; IM-1021, a ROR1 antibody-drug conjugate under evaluation in a Phase 1 trial; and IM-3050, a FAP-targeted radioligand therapy with IND clearance and a planned Phase 1 trial. The company is also advancing preclinical solid tumor ADCs, including IM-1617, IM-1340, and IM-1335.

Share on Social Networks: